Sheraton Crystal City
Arlington, VA
Sept. 19-20, 2012
For more information on MTLI programs, visit our website
www.advamedmtli.org
Medical Device Tax
Workshop
Medical Device Tax Workshop
Sheraton Crystal City Arlington, VA
September 19-20, 2012
Wednesday, September 19 8:30 – 9:00 BREAKFAST AND REGISTRATION 9:00 – 9:05 AdvaMed Introduction 9:05 – 9:30 Legal Update
Christopher L. White, Senior Executive Vice President, General Counsel, AdvaMed
Legislative and Regulatory update
AdvaMed participation in guidance process 9:30 – 11:00 How Does the Device Tax Work?
Lew Fernandez, Director, Tax, PricewaterhouseCoopers
Understanding the latest IRS guidance: exemptions; safe harbor; taxable medical devices
Constructive pricing
Ruling process/additional guidance 11:00 – 11:30 BREAK 11:30 – 12:30 Implementation Issues
Rosemary Becchi, Partner, Patton Boggs LLP George J. Schutzer, Partner, Patton Boggs, LLP
Taxable and non-taxable uses
Registration and certification
Reporting, payment, and penalties 12:30 – 1:30 LUNCH 1:30 – 3:00 Implementation Issues Panel: Ask the Experts
Rosemary Becchi, Partner, Patton Boggs LLP Lew Fernandez, Director, Tax, PricewaterhouseCoopers Chris Ohmes, Partner, Ernst & Young John Seabrook, Partner, Deloitte Tax LLP George J. Schutzer, Partner, Patton Boggs, LLP Michael Udell, Senior Manager, Ernst & Young
Manufacturing activities: kitting and contract management
What’s a sale and what’s the price
Leases and rentals
Accounting systems
Important Notice The information provided in this course represents the personal opinions of the instructors and does not necessarily represent the opinions of AdvaMed staff. Companies relying on the information do so at their own risk and assume the risk of any subsequent liability that results from relying on the information. The information does not constitute legal advice.
3:00 – 3:30
BREAK
3:30 – 4:30 What Leading Companies Are Doing Right Now
Chris Ohmes, Partner, Ernst & Young
Michael Udell, Senior Manager, Ernst & Young
4:30 – 5:30 RECEPTION Thursday, September 20
8:30 – 9:00
BREAKFAST
9:00 – 11:00 Overview of Implications for Industry Sectors Implantables, Wound Care, Surgical and Medical Supplies; Diagnostics and Capital Equipment
Chris Ohmes, Partner, Ernst & Young
Michael Udell, Senior Manager, Ernst & Young Software and Systems
Stephen Metoyer, Principal, Deloitte Tax LLP 11:00 ADJOURNMENT
1
Medical Device Tax Workshop
Faculty Biographies
Rosemary Becchi is a Partner with Patton Boggs. She advocates on behalf of companies on a broad array of regulatory and legislative issues, with an emphasis on tax and financial services matters. Using her combination of public and private sector experience, Ms. Becchi helps clients further their tax and financial services policy initiatives by providing strategic legal and business counsel, fostering critical relationships, and implementing successful long-term policy strategies. Ms. Becchi began her career in the Office of the Chief Counsel at the Internal Revenue Service, where she developed and drafted rulings and regulations on national tax policy. She then served as tax counsel on the Majority Staff of the Senate Finance Committee where she played a key role in developing legislation at the committee, including legislation on corporate and income tax accounting issues, the R&D tax credit, methods of accounting, depreciation, education savings and charitable giving. After leaving Capitol Hill, Ms. Becchi worked at Arthur Andersen’s Office of Federal Tax Services providing tax advice to corporate clients on complex tax transactions. Following that she joined Citigroup’s Federal Government Relations Division and was responsible for representing Citigroup on its federal and state corporate tax, international, corporate governance, accounting, and auditing issues. Ms. Becchi later joined Fidelity Investments where she directed all of Fidelity’s tax legislative and regulatory issues, including issues that impacted section 529 college savings plans, retirement and health savings, deferred compensation, and defined contribution plans. During her career, Ms. Becchi also served as a member of the Board of the Investment Committee for the Virginia College Savings Plan, where the committee oversaw the selection of investments options for the plan. Before joining Patton Boggs, she was president and founder of Becchi Consulting, where she advised businesses on operational, legal, legislative and regulatory matters. Lew Fernandez is a Director in PricewaterhouseCoopers LLP’s National Tax Services office in Washington, D.C. where he is a member of the Tax Controversies ands Dispute Resolution Team. Lew specializes in federal excise tax, IRS practice and procedure, and the federal income tax consequences of government settlements. Lew spent twenty nine years with the IRS Office of Chief Counsel in the national office. He has held positions of responsibility in both the litigation and technical functions of the Office of Chief Counsel and appeared before the United States Tax Court on behalf of the IRS. His last executive position with the Office of Chief Counsel was as Associate Chief Counsel (Income Tax and Accounting) where he supervised a staff of 129, including approximately 90 tax professionals. As Associate Chief Counsel, he was the chief legal officer to the IRS on matters within the jurisdiction of his office including accounting methods and periods, capitalization and deduction of costs, casualty and other losses and a myriad of other income tax issues ranging from the scope of gross income to fundamental credits, deductions, inclusions and exclusions. Prior to becoming Associate Chief Counsel, Lew served as Deputy Associate Chief Counsel (Passthroughs and Special Industries) and directed the tax controversy matters of that office and supervised the work of a number of the legal branches including Branch 7 which had jurisdiction over most federal excise taxes administered by the IRS. Lew joined PricewaterhouseCoopers LLP in September 2007.
2
Lew is an attorney licensed in Pennsylvania, and is also licensed to practice before the United States Tax Court. He received his JD from the Seton Hall University School of Law in 1978. He also holds an MBA from the University of Pittsburgh School of Business and a BS in Management from Robert Morris University from which he graduated with honors. Stephen Metoyer is a Principal with Deloitte Tax LLP. He has over 20 years of experience in automating indirect tax systems and processes. Currently, he leads the indirect tax component of Deloitte’s Tax Management Consulting (“TMC”) practice. Stephen has significant experience designing, configuring, implementing and managing various integration projects. He has created tax technology solutions in many environments that address a wide range of transaction tax issues. He has also addressed indirect tax technology and process issues in the procure-to-pay area. Additionally, Stephen has worked extensively with tax data retention and exemption certificate management. Stephen began his career in the tax department of a Fortune 100 Company and was responsible for value added, sales, use and excise taxes. After being assigned as a tax department representative to an ERP integration team, he began his training and work in the areas of technology and process redesign. Stephen obtained his Masters in Business Administration and Bachelors of Science in Accounting from Louisiana Tech University. He speaks regularly at forums and conferences regarding indirect tax automation and process improvement. Christopher J. Ohmes is a member of Ernst & Young LLP's National Tax Department in Washington, D.C. Chris is a co-leader of the firm's research credit practice, with a particular emphasis on helping clients deal with Treasury and the Internal Revenue Service. Chris also advises clients on tax accounting issues relating to intangible assets. Prior to joining Ernst & Young LLP, Chris was a Senior Tax Specialist in the Treasury Department's Office of Tax Policy. His primary areas of concentration at Treasury included the research credit, self-created intangibles, depreciation matters, the mechanics of tax accounting method changes, licensing, and leasing issues. Prior to his Treasury experience, Chris spent 11 years in the national tax office of another international accounting firm, providing services to clients in the research credit, intangibles, and tax accounting areas and advising clients on tax policy issues in these areas and in risk management matters. Chris has been a frequent speaker on tax topics throughout his career. He also developed and taught several training classes on tax technical subjects. Prior to joining Treasury, Chris was a contributing author of the taxation chapter of the book Software Industry Accounting, dealing with the taxation of software companies. Chris received a B.B.A. in Accounting from Marquette University and an M.S. in Taxation from the University of Wisconsin-Milwaukee. He is a certified public accountant licensed in the state of Wisconsin and the District of Columbia. Chris is a member of the American Institute of Certified Public Accountants and the Wisconsin Institute of Certified Public Accountants. John Seabrook is a Partner within Deloitte’s National Federal Tax Services (NFTS) and is leading our firm’s service delivery related to the Medical Device Excise Tax (MDET). John also serves on the NFTS Management Committee, the Deloitte Tax Xchange, the Deloitte Tax Innovation Council, and the Tax Task Force for our Federal & State Government Sector Practice. John has served across a wide variety of federal tax areas and has spent the past decade forming practices around new tax legislation and has been involved with tax implications of the Affordable Care Act since its enactment in March 2010. John practices nationally and is based out of our Charlotte office. He received his Bachelor of Science and Masters Degree of Accounting from Clemson University. John holds a CPA License in North and South Carolina and has over 19 years experience with the Big 4; including 12 years at Deloitte.
3
George Schutzer is chair of the Tax, Benefits and Nonprofit Organizations practice at Patton Boggs, LLP, where he has practiced tax law for the last 32 years. His practice focuses on tax components of business transactions, tax-exempt organizations and tax compliance. He has advised companies and trade associations on environmental excise taxes, exemptions from certain retail and communications excise taxes and manufacturers excises taxes, including the tax on medical devices. Mr. Schutzer is a graduate of Williams College and Yale Law School. He spoke at an AdvaMed webinar on the medical device excise tax in July 2010 and at AdvaMeds’s Medical Device Excise Tax Workshop in Irvine, California, in April. Michael Udell is a member of the Quantitative Economics and Statistics (QUEST) group at Ernst & Young LLP in Washington, D.C., where he works on federal tax policy issues. Mike assists the firm's clients with economic analysis of federal tax policy issues including the development and revenue analysis of legislative proposals. Before joining Ernst & Young LLP, Mike was an economist on the staff of the Joint Committee on Taxation for 17 years from 1991 through 2008. During that time, Mike developed models simulating the US tax system and worked on a wide range of federal tax policy issues with particular emphasis on estate and gift taxes and tax compliance proposals. He analyzed and estimated every estate and gift tax proposal considered by the Congress between 1995 and 2008 and has developed numerous tax compliance proposals that have been enacted into law. As a member of the Joint Committee on Taxation staff, he has worked closely with House Ways and Means and Senate Finance Committee tax staffs as well as Treasury and IRS personnel in the development and analysis of tax legislative proposals. Mike received his B.A. from the University of Pennsylvania and his Ph.D. from the California Institute of Technology. Christopher L. White, Esq. is Executive Vice President, General Counsel, and Secretary of the Advanced Medical Technology Association (AdvaMed). Mr. White manages AdvaMed’s Legal Committee to develop and promote positions impacting patient access to medical technology. Mr. White leads the Association’s working group developing device tax implementation, policy and comments. He testified before the Senate Aging Committee on the Physician Payment Sunshine legislation, led the drafting team substantially revising the AdvaMed Code in 2008-2009, and leads AdvaMed’s Code of Ethics related programs and activities. He led the negotiating team to draft the Kuala Lumpur Principles, harmonizing industry Codes of Ethics in Asia. As chief legal officer, he also provides counsel on commercial contracts, corporate transactions, and legislative and regulatory matters. Prior to joining AdvaMed's staff in February 2006, Mr. White was a Partner at Morgan Lewis, Counselors at Law, in the FDA/Healthcare Regulation Practice, focusing his practice on Centers for Medicare and Medicaid Services' regulatory issues affecting medical technology innovators, including device manufacturers, biotechnology companies and healthcare service providers. His work included seeking Medicare coverage, coding, and reimbursement determinations for new medical technology for device manufacturers, developers, distributors and suppliers. Before 2001, Mr. White was a partner with Gardner, Carton & Douglas, LLP national health care practice, where he concentrated on health care regulatory and fraud and abuse matters. Mr. White received his B.A. in Biology from Wake Forest University, and received his J.D. from The Catholic University of America. He serves as a frequent speaker and author on health care regulatory and fraud and abuse issues.
1
Medical Device Tax Workshop
Sheraton Crystal City
Arlington, VA
Sept. 19-20, 2012
List of Attendees
Andrew Beaudry
Badge Name: Andy Controller Sybron Dental Specialties
Orange, CA
Rosemary Becchi Badge Name: Rosemary Partner
Patton Boggs LLP Washington, DC
John Bergeron Badge Name: John
Vice President & Treasurer Zoll Medical Corporation
Chelmsford, MA Rachelle Bial
Badge Name: Rachelle Accounting Manager
Acumed LLC Hillsboro, OR
Victoria Blaine Badge Name: Victoria
Vice President, Commercial Operations QIAGEN Sciences
Germantown, MD Cindi Brooks
Badge Name: Cindi Manager, Meetings and Conferences
Advanced Medical Technology Association Washington, DC
Terrence Byrnes
Badge Name: Terry Tax Manager Carestream Health, Inc.
Rochester, NY
Michael Cacace Badge Name: Michael Director Federal Tax
B. Braun Medical Inc. Bethlehem, PA
Charles Carignan MD Badge Name: Chuck
President and Chief Executive Officer NinePoint Medical, Inc.
Cambridge, MA Michael Corrente
Badge Name: Michael Managing Director
CBIZ Tofias Providence, RI
Sean Darling Badge Name: Sean
Controller CFI Medical Solutions, Inc.
Fenton, MI Peter Donato
Badge Name: Peter Corporate Controller
Cyberonics, Inc. Houston, TX
2
Diane Duffey Badge Name: Diane
Transaction Tax Senior Terumo BCT, Inc.
Lakewood, CO Lewis Fernandez
Badge Name: Lew Director, Tax
PricewaterhouseCoopers LLP Washington, DC
Lloyd Fort Badge Name: Lloyd
Director, Tax Planning & Special Projects Cardinal Health
Dublin, OH
Scott Froehlich Badge Name: Scott
Global Tax Director Terumo BCT, Inc. Lakewood, CO
Deborah Gangi
Badge Name: Debbie Manager, Indirect Taxes Smith & Nephew, Inc.
Andover, MA
Sharon Garber Badge Name: Sharon Controller
Spine Wave Inc. Shelton, CT
Dennis Genge Badge Name: Dennis
Vice President and Chief Financial Officer
Regenesis Biomedical, Inc. Scottsdale, AZ
Scott Gill Badge Name: Scott
Chief Financial Officer ISTO Technologies, Inc. Saint Louis, MO
Tom Guttridge Badge Name: Tom
Controller Diagnostica Stago, Inc.
Parsippany, NJ Dane Healy
Badge Name: Dane Manager, Tax Compliance
Covidien Mansfield, MA
Bruce Heugel Badge Name: Bruce
Senior Vice President & Chief Financial Officer B. Braun Medical Inc.
Bethlehem, PA
Thomas Holcombe Badge Name: Tom
Director Accounting, Financial Planning and Analysis Straumann USA LLC
Andover, MA
Lynn Hollenbeck-Konze CPA Badge Name: Lynn Senior Tax Analyst
Benco Dental Supply Company Pittston, PA
Greg Huck Badge Name: Greg
President Vitalcor, Inc.
Westmont, IL Gary Jensen
Badge Name: Gary Vice President Finance, Chief Financial
Officer ArjoHuntleigh Addison, IL
Shelly Jones
Badge Name: Shelly Assistant Controller VidaCare Corporation
Shavano Park, TX
3
Mark Kebadjian Badge Name: Mark
Managing Director CBIZ Tofias
Boston, MA Lee Kim
Badge Name: Lee Chief Financial Officer
Freedom Innovations Irvine, CA
Chris Klein Badge Name: Chris
Controller Quest Medical, Inc. Allen, TX
Mark Kuhn
Badge Name: Mark Vice President Finance
Danaher Corporation Washington, DC
Richard Kurz Badge Name: Rick
Vice President, Controller & Treasurer Hitachi Medical Systems America Twinsburg, OH
Scott Larson
Badge Name: Scott Senior Vice President, Secretary & General Counsel
Terumo BCT, Inc. Lakewood, CO
Jonathan Leigh Badge Name: Jonathan
Tax Manager CareFusion Corporation
San Diego, CA YaNan Liu
Badge Name: YaNan Accounting Administrative Assistant
Baylis Medical Company Inc. Montreal, Canada
Jennifer Lynn Badge Name: Jen
Financial Controller, Corin USA Corin USA Limited
Tampa, FL Brandon Mark CPA
Badge Name: Brandon Tax Director
Cyberonics, Inc. Houston, TX
Annette Matovelle Badge Name: Annette
Controller OrthoSensor, Inc. Sunrise, FL
Catherine Matthes
Badge Name: Cathy Chief Financial Officer
Veniti Inc. Des Peres, MO
Lindsay Maxwell Badge Name: Lindsay
Senior Accountant CryoLife, Inc. Kennesaw, GA
Ronald McCarley
Badge Name: Rick President & Chief Executive Officer OPHTEC USA, Inc.
Boca Raton, FL
Nancy McCarley Badge Name: Nancy Accounting Manager
OPHTEC USA, Inc. Boca Raton, FL
Richard McEnroe Badge Name: Rich
Director, U.S. Healthcare Policy Hollister Incorporated
Libertyville, IL
4
Nicole Metcho Badge Name: Nicole
Tax Director FXI
Media, PA Stephen Metoyer
Badge Name: Stephen Tax Principal, Tax Management
Consulting Practice Deloitte Tax LLP Houston, TX
Robert Milliard
Badge Name: Bob Controller Instrumentation Laboratory
Bedford, MA
Marilyn Murphy Badge Name: Marilyn
Tax Manager Hollister Incorporated Libertyville, IL
Deborah Murray
Badge Name: Debbie Director of Tax - Americas Gambro Renal Products, Inc.
Lakewood, CO
Peter Muszka Badge Name: Peter Director of Business Process Support
Straumann USA LLC Andover, MA
Heather Nazzaro Badge Name: Heather
State Tax Manager Gambro Renal Products, Inc.
Lakewood, CO Marni Nicholas
Badge Name: Marni Senior Manager, Tax Compliance
Covidien Mansfield, MA
Christopher Ohmes Badge Name: Chris
Partner Ernst & Young LLP
Washington, DC Carl Olofson
Badge Name: Carl Director, Federal Tax
Hospira, Inc. Lake Forest, IL
Jamien Payne Badge Name: Jamien
Marketing Manager Advanced Medical Technology Association
Washington, DC
Bob Pereira Badge Name: Bob
Director of Governance Zoll Medical Corporation Chelmsford, MA
Rob Phillips
Badge Name: Rob IT Manager CFI Medical Solutions, Inc.
Fenton, MI
Ronald Rice Badge Name: Ron Sr. Tax Analyst
Instrumentation Laboratory Bedford, MA
Keith Rogers Badge Name: Keith
US Tax Counsel Alcon Laboratories, Inc.
Fort Worth, TX Joseph Rolley
Badge Name: Joe Vice President, Global Government
Affairs and Health Policy ConvaTec Inc. Skillman, NJ
5
Linda Rouse O'Neill Badge Name: Linda
Vice President of Government Affairs Health Industry Distributors
Association Alexandria, VA
Jennifer Sargeant Badge Name: Jen
Director, Program Development, MTLI Advanced Medical Technology Association
Washington, DC
Glenn Sasaki Badge Name: Glenn CFO
Glidewell Laboratories Newport Beach, CA
Cheryl Schramm
Badge Name: Cheryl Vice President Finance Heidelberg Engineering, Inc.
Carlsbad, CA
George Schutzer Badge Name: George Partner
Patton Boggs LLP Washington, DC
John Seabrook Badge Name: John
Tax Partner, National Federal Tax Services
Deloitte Tax LLP Charlotte, NC
Laurence Smith Badge Name: Larry
Vice President, Tax Danaher Corporation Washington, DC
Raymond Szafranski Jr
Badge Name: Ray CFO Tecan US, Inc.
Morrisville, NC
Manu Talwar CPA
Badge Name: Manu Chief Financial Officer
Micronics, Inc. Redmond, WA
Michael Udell Badge Name: Michael
Senior Manager Ernst & Young LLP Washington, DC
Christopher White
Badge Name: Chris Executive Vice President, General Counsel
Advanced Medical Technology Association
Washington, DC
Patricia Wilch Badge Name: Patt Vice President, Market Management &
Medical Affairs - Molecular Diagnostics QIAGEN Inc.
Germantown, MD Frank Wilton
Badge Name: Frank Senior Vice President, Membership &
Marketing Advanced Medical Technology Association
Washington, DC
John Yilling Badge Name: Louie Director of Finance
MED-EL Corporation (North America)
Durham, NC
Medical Device Tax Legal UpdateMedical Technology Learning Institute
September 19, 2012
Christopher WhiteSenior Executive Vice President,
General CounselAdvaMed
Statutory Elements of the Medical Device Excise Tax• 26 U.S.C. §4191(a) imposes “on the sale of any taxable medical device by the
manufacturer, producer, or importer a tax equal to 2.3 percent of the price for which so sold”
• “Taxable medical device” means “any device (as defined in section 201(h) of the [FFDCA]) intended for humans”
• “Retail” exemption for “eyeglasses, contact lenses, hearing aids, and any other medical device determined by the Secretary to be of a type which is generally purchased by the general public at retail for individual use”
• Statute imposes excise tax on sales to and for the exclusive use of a State or local government or nonprofit educational organization
• Statute excludes imposition of tax on exported medical devices (but requires registration under 26 U.S.C. §4222)
• Statute and legislative history does not specify whether excise tax is deductible
The Medical Device Excise Tax
2
Jun‘10
• Forms Device Tax Working Group focused on Industry Guidance• Forms Device Tax Working Group focused on Industry Guidance
Oct‘10
• Meets w/ Treasury on industry/product characteristics; requests excise tax guidance as priority issue; seeks public process
• Meets w/ Treasury on industry/product characteristics; requests excise tax guidance as priority issue; seeks public process
Dec‘10
• Meets w/ IRS/Treasury officials; Treasury issues Notice requesting public comments
• Meets w/ IRS/Treasury officials; Treasury issues Notice requesting public comments
Mar‘11
• Submits initial recommendations highlighting Principles & definitions of “Medical Device,” Retail Exemption, Manufacturer, Price, Taxable “Use”
• Submits initial recommendations highlighting Principles & definitions of “Medical Device,” Retail Exemption, Manufacturer, Price, Taxable “Use”
Apr‘11
• Meets with IRS/Treasury officials to discuss written comments• Meets with IRS/Treasury officials to discuss written comments
Jul‘11
• Submits supplemental recommendations highlighting combination products, kits, leases, & rebates
• Submits supplemental recommendations highlighting combination products, kits, leases, & rebates
Sept‘11
• Meets with IRS/Treasury officials• Meets with IRS/Treasury officials
AdvaMed’s Regulatory Activity
3
Oct & Nov ‘11
• Working Group defers on additional issues pending IRS guidance• Working Group defers on additional issues pending IRS guidance
Feb. 7,‘12
• IRS issues proposed regulations• IRS issues proposed regulations
May 7,‘12
• Submits public comments on proposed regulations• Submits public comments on proposed regulations
May 16,‘12
• Testifies before IRS in public hearing on proposed regulations• Testifies before IRS in public hearing on proposed regulations
Jan 1,‘13
• Effective date of medical device excise tax• Effective date of medical device excise tax
AdvaMed’s Regulatory Activity
4
AdvaMed Participation in Guidance Process
May 16, 2012: AdvaMed testifies before IRS
5
AdvaMed Participation in Guidance ProcessIRS (Notice 2010-89) requested comments
on the (1) retail exemption and (2) application of existing manufacturer’s excise tax rules to medical device excise tax
AdvaMed’s recommendations of March 22, July 5, and July 29, 2011 addressed the following topics, among others:▫ Definition of “taxable medical device”▫ Clarification of retail exemption ▫ Taxable “sale” or “use”▫ Price subject to tax▫ Definition of manufacturer▫ Kitting and bundling▫ Leases and rentals
AdvaMed made 21 separate technical Recommendations
Other stakeholder commenters: Members of Congress, Companies, Distributors, Hospitals, Professionals, Homecare, Dental, Law Firms
6
AdvaMed Participation in Guidance Process
Final Comments: May 7, 2012
Priority Issues:• Taxable Use• Retail exemption• Rebates• Constructive Pricing
7
Legislative Status
• Five repeal bills pending in House and Senate
• Rep. Paulsen’s bill with 240 co-sponsors; passed by the House in early June 2012
8
� 103 Day from Effective Date
� National Federation of Independent Business et al. v.
Sebelius, Secretary of Health and Human Services, et al.,
132 S. Ct. 2566 (Jun. 28, 2012) - ACA is within the
Congress's power to lay and collect taxes.
� Effect of Election Results.
� Final regulations Expected this Fall
� I.R.C. § 4191(a) provides that there is hereby imposed on the sale of any taxable medical device by the manufacturer, producer, or importer a tax equal to 2.3 percent of the price for which so sold.
� "Pressure points" in the statute - Definitions of the terms:
Sale
Taxable Medical Device
Manufacturer
Price
� Terms of art described in section 4191(a) or in longstanding Subchapters applying Special Provisions to Chapter 32 Manufacturers Taxes
� I.R.C. § 4221(d)(1) - "Manufacturer" includes a producer or importer of an article.
� Treas. Reg. § 48.0-2(a)(4)(i) - The term manufacturer includes any person who produces a taxable article from scrap, salvage, or junk material, or from new or raw material, by processing, manipulating, or changing the form of an article or by combining or assembling two or more articles. The term also includes a “producer” and an “importer”. An “importer” of a taxable article is any person who brings such an article into the United States from a source outside the United States, or who withdraws such an article from a customs bonded warehouse for sale or use in the United States.
� Nominal manufacturer not treated as Chapter 32 manufacturer if:
� Under certain circumstances, as where a person manufactures or produces a taxable article for another person who furnishes materials under an agreement whereby the person who furnished the materials retains title thereto and to the finished article, the person for whom the taxable article is manufactured or produced, and not the person who actually manufactures or produces it, will be considered the manufacturer.
� Generally where a company not only owns the patents under which a taxable article is fabricated by another company, but also exercises control as to the amounts to be so fabricated and has exclusive rights to the output, and where the fabricator is not free to sell elsewhere, the company owning the patents is considered to be the manufacturer for purposes of the manufacturers excise tax. See Polaroid Corporation v. United States, 235 F.2d 276 (1st Cir. 1956), cert. den. 352 U.S. 953 (1956).
� Nominal importer not treated as Chapter 32 importer -
� If the nominal importer of a taxable article is not its
beneficial owner (for example, the nominal importer is a
customs broker engaged by the beneficial owner), the
beneficial owner is the “importer” of the article for
purposes of chapter 32 and is liable for tax on his sale or
use of the article in the United States.
� First purchaser in U.S. who arranges as principal and not as
agent for, or is the inducing and efficient cause of, goods
being brought into the United States for use or sale.
� Treas. Reg. § 48.0-2(a)(5) - The term sale means an
agreement whereby the seller transfers the property (that
is, the title or the substantial incidents of ownership) in
goods to the buyer for a consideration called the price,
which may consist of money, services, or other things.
� I.R.C. § 4217 Leases - the lease of an article (including any
renewal or any extension of a lease or any subsequent
lease of such article) by the manufacturer, producer, or
importer shall be considered a sale of such article.
� "Total tax" limitation and coordination with § 4216(c)(1)
� Effect of rule in preamble to proposed regulations
� I.R.C. § 4218 Uses - If any person manufactures, produces, or imports an article and uses it (otherwise than as material in the manufacture or production of, or as a component part of, another article taxable under this chapter to be manufactured or produced by him), then he shall be liable for tax under this chapter in the same manner as if such article were sold by him.
� Rev. Rul. 60-290, 1960-2 CB 331 - The manufacturer of a taxable article is liable for the manufacturers excise tax when he first uses the taxable article as a demonstrator in his showroom. No manufacturers excise tax is incurred on a later sale of the used taxable article.
� Contrast position taken by IRS Counsel in case specific guidance - demonstration of a new taxable article to the person who buys the article is not a section 4218 taxable use. General v. Specific demonstration purposes make a difference?
� Samples, bonus or free articles - No section 4218 use
because of title transfer. But, can be viewed as purchase
price adjustment in appropriate circumstances or a sale
for consideration other than money.
� Tax Free Sales
� I.R.C § 4221(a)(1) - for use by the purchaser for further manufacture, or for resale by the purchaser to a second purchaser for use by such second purchaser in further manufacture.
� I.R.C. § 4221(a)(2) - for export, or for resale by the purchaser to a second purchaser for export.
� Registration requirements - Form 637 Application for Registration (For Certain Excise Tax Activities)
� Substantiation requirements
� A taxable medical device is statutorily defined as "any device (as defined in section 201(h) of the [FFDCA] intended for humans."
� The proposed regulations state that a taxable medical device means "a device that is listed as a device with the [FDA] under section 510(j) of the [FFDCA] and 21 CFR Part 807, pursuant to FDA requirements."
� Statute specifically exempts eyeglasses, contact lenses, and hearing aids.
� Statute also authorizes the Secretary to determine other exempt devices “of a type which is generally purchased by the general public at retail for individual use” - primary purpose of the proposed regulations
� When statutory exemptions, the preamble to the proposed regulations and the proposed substantive rules are taken together, the following principles emerge:
� FDA listed devices are presumptively taxable, but the following devices are exempt:
� Devices that are not FDA listed
� Devices intended for use exclusively in veterinary medicine (but devices with dual human /veterinary are not exempt if listed with the FDA)
� "Research Use Only" Devices meeting the requirements of 21 CFR 807.65(f)
� Devices subject to an Investigational Device Exemption under 21 CFR Part 812.
� Eyeglasses, contact lenses and hearing aids
� Devices falling into the Retail Exemption
� The proposed regulations provide a two-pronged facts and circumstances test and a "Safe Harbor for determining whether a device is exempt under the retail exemption
� "Safe Harbor" - Examine this test first. Devices that fall within the safe harbor are automatically exempt with no further examination.
� “Safe Harbor” - The following devices will be considered to be of a type generally purchased by the general public at retail for individual use:
(A) Devices that are included in the FDA’s online IVD Home Use Lab Tests (Over-the-Counter Tests) database, available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfIVD/Search.cfm.
(B) Devices that are described as “OTC” or “over the counter” devices in the relevant FDA classification regulation heading.
(C) Devices that are described as “OTC” or “over the counter” devices in the FDA’s product code name, the FDA’s device classification name, or the “classification name” field in the FDA’s device registration and listing database, available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm.
(D) Devices that qualify as durable medical equipment, prosthetics, orthotics, and supplies, as described in Subpart C of 42 CFR Part 414 (Parenteral and Enteral Nutrition) and Subpart D of 42 CFR Part 414 (Durable Medical Equipment and Prosthetic and Orthotic Devices), for which payment is available on a purchase basis under Medicare Part B payment rules, and are--
(1) “Prosthetic and orthotic devices,” as defined in 42 CFR 414.202, that do not require implantation or insertion by a medical professional;
(2) “Parenteral and enteral nutrients, equipment, and supplies” as defined in 42 CFR 411.351 and described in 42 CFR 414.102(b);
(3) “Customized items” as described in 42 CFR
414.224;
(4) “Therapeutic shoes,” as described in 42 CFR
414.228(c); or
(5) Supplies necessary for the effective use of DME,
as described in section 110.3 of chapter 15 of the
Medicare Benefit Policy Manual (Centers for Medicare
and Medicaid Studies Publication 100-02).
� The Two-Pronged Facts and Circumstances test. Objective is to fall into the first prong and out of the second prong in order to achieve exemption.
� First Prong - Regularly available for purchase and use by individual consumers.
(A) Consumers who are not medical professionals can purchase the device through retail businesses that also sell items other than medical devices, such as drug stores, supermarkets, and similar vendors.
(B) Consumers who are not medical professionals can use the device safely and effectively for its intended medical purpose with minimal or no training from a medical professional.
(C) The device is classified by the FDA under Subpart D of 21 CFR Part 890 (Physical Medicine Devices).
� Second Prong - Primarily for use in a medical
institution or office by a medical professional.
(A) The device generally must be implanted,
inserted, operated, or otherwise administered
by a medical professional.
(B) The cost to acquire, maintain, and/or use
the device requires a large initial investment and/or
ongoing expenditure that is not affordable for
the average consumer.
(C) The device is a Class III device under the FDA
system of classification.
(D) The device is classified by the FDA under parts,
subparts and section of 21 CFR (FDA regulations).
(E) The device qualifies as durable medical
equipment, prosthetics, orthotics, and supplies for
which payment is available exclusively on a rental
basis under the Medicare Part B payment rules, and is
an “item requiring frequent and substantial
servicing” as defined in 42 CFR 414.222.
� List of factors is non-exclusive
� IRS and Treasury have asked for additional
factors (e.g., labeling, internet sales), examples
of safe harbors the industry would like to be
considered for inclusion in the final regulations.
� IRS Office of Chief Counsel may be willing to
issue private letter rulings to address the Retail
Exemption as it applies to specific medical
devices.
� Final regulations expected this fall
� Manufacturers excise taxes from their inception in 1932
were intended to apply as a percentage of the price at
which manufacturers sold to volume purchasers,
traditionally at the wholesaler level. Shakespeare Co. v.
U.S., 419 F.2d 839 (Ct. Cl. 1969), cert. denied, 400 U.S.
820 (1970).
� Congress early recognized, however, that competitive
inequities were created among manufacturers of like goods
who sold at different levels of distribution, e.g., a
manufacturer which sold at retail rather than to
wholesalers charged a higher price for its goods because of
increased expenses of distribution at retail.
� The constructive price rules are designed to
result in a downward adjustment of price when
taxable articles are sold directly a retail. S.
Rep. No. 2090, 85TH Cong., 2ND Sess. (1958).
� The constructive price rules are also designed to
result in an upward adjustment when taxable
articles are sold in transactions that are not at
arm's length for a price that is less than fair
market price. Id.
� I.R.C. § 4216(b)(1) - In general, construct a sale
price when a taxable articles is:
(A) Sold at retail,
(B) Sold on consignment, or
(C) Sold (otherwise than through an arm's length
transaction) at less than the fair market price.
� Retail sale = sale of an article to a purchaser
who intends to use or lease the article rather
than resell it. Treas. Reg. § 48.4216(b)-1(c).
� Consignment sale = it is sold while it is on
consignment to a person that has the right to
sell, and does sell, such article in its own name,
but never receives title to the article from the
manufacturer. Treas. Reg. § 48.4216(b)-2(d).
� Sales otherwise than at arm’s length =
(1) One of the parties is controlled (in law or in
fact) by the other, or there is common control,
whether or not such control is actually exercised
to influence the sale price, or
(2) The sale is made pursuant to special
arrangements between a manufacturer and a
purchaser.
� Inter-company sales between related entities are per se not at arm’s length.
� At less than fair market price = IRS will generally use the constructive price to determine the "floor" fair market price unless the taxpayer can show that a different, lower fair market price is "clearly applicable." S. Rep. No. 91-1444, 91st Cong., 2d Sess. (1971); IRS and Treasury published and case specific guidance.
� IRS constructive price can be rebutted by expert testimony; market data etc. Storm Plastics, Inc. v. U.S., 770 F.2d 148 (10th Cir. 1985), acq. Rev. Rul. 89-47, 1989-1 CB 295.
� Any inter-company sales pricing methodology that yields a substantially lower result than would result under the constructive pricing rules is likely to be challenged.
� I.R.C. § 4216(b)(1) General Rule - the tax under this chapter shall
be computed on the price for which such articles are sold, in the
ordinary course of trade, by manufacturers or producers thereof,
as determined by the Secretary.
� I.R.C. § 4216(b)(1) General Rule for Retail Sales - In the case of
an article sold at retail, the computation shall be on whichever
of the following prices is the lower: (i) the price for which such
article is sold, or (ii) the highest price for which such articles are
sold to wholesale distributors, in the ordinary course of trade, by
manufacturers or producers thereof, as determined by the
Secretary.
� I.R.C. § 4216(b)(2) - Special Rule for sales at retail or to retailers:
- If special rule applies, then general rule above is not applicable.
- If an article is sold at retail or to a retailer, and if--
(A) the manufacturer, producer, or importer of such article regularly sells such articles at retail or to retailers, as the case may be,
(B) the manufacturer, producer, or importer of such article regularly sells such articles to one or more wholesale distributors in arm's length transactions and he establishes that his prices in such cases are determined without regard to any tax benefit under this paragraph, and
(C) the transaction is an arm's length transaction
the tax under this chapter shall (if based on the price for which the article is sold) be computed on whichever of the following prices is the lower: (i) the price for which such article is sold, or (ii) the highest price for which such articles are sold by such manufacturer, producer, or importer to wholesale distributors.
� Retailer = a person engaged in the business of selling
taxable articles at retail. Treas. Reg. § 48.4216(b)-1(c).
� Wholesale distributor = A person engaged in the business of
selling taxable articles to persons engaged in the business
of reselling such articles. Id.
� Treas. Reg. § 48.4216(b)-2(d) General Rule for Consignment
Sales - Ordinarily, the constructive sale price of an article
sold on consignment is the net price received by the
manufacturer from the consignee.
� What about intercompany sales that are not at fair market price?
� I.R.C. § 4216(b)(3) - for purposes of the general rule under section 4216(b)(1), if—
(A) the manufacturer, producer, or importer of an article regularly sells such article to a distributor which is a member of the same affiliated group of corporations (as defined in section 1504(a)) as the manufacturer, producer, or importer, and
(B) such distributor regularly sells such article to one or more independent retailers, but does not regularly sell to wholesale distributors,
� The constructive sale price of such article shall be 90 percent of the lowest price for which such distributor regularly sells such article in arm's-length transactions to such independent retailers. The price determined under this paragraph shall not be adjusted for any exclusion (except for the tax imposed on such article) or readjustments under subsections (a) and (e) and under section 6416(b)(1).
� If both the (b)(3) rule and the (b)(4) rule described below apply with respect to an article, the constructive sale price for such article shall be the lower of the constructive sale price determined under (b)(3) or (b) 4.
� I.R.C. § 4216(b)(4) statute presents a complicated rule.
� Stated as simply as possible, for purposes of the general rule under section 4216(b)(1), if --
(A) the manufacturer, producer, or importer of an article regularly sells (except for tax-free sales) only to a distributor which is a member of the same affiliated group of corporations (as defined in section 1504(a)) as the manufacturer, producer, or importer,
(B) the distributor regularly sells (except for tax-free sales) such article only to retailers, and
(C) the normal method of sales for such articles within the industry by manufacturers, producers, or importers is to sell such articles in arm's-length transactions to distributors,
the constructive sale price for such article shall be the price at which such article is sold to retailers by the distributor, reduced by a percentage equal to the mark-up used by independent distributors in that industry.
� IRS and Treasury guidance provide that the (b)(3) and (b)(4) rules are applicable even if the related entities are not section 1504 affiliates.
� Secretary's delegate, the Commissioner, will construct a price under the general power in section 4216(b)(1).
� Rules can be found in various pieces of published guidance and case specific guidance (PLRs; TAMs; CCAs)
� Examine a few scenarios -
Scenario 1: Manufacturer sells a taxable medical device directly to a hospital (assume theory in HCA applies). No sales of the identical article to wholesale distributors.
Scenario 2: Manufacturer sells a taxable article to a related distributor that sells to a hospital. No sales of the identical article to wholesale distributors by the selling company.
Scenario 3: Manufacturer sells a taxable article directly to a retailer. No sales of the identical article to wholesale distributors.
Scenario 4: Manufacturer sells a taxable article to a related distributor that sells to a wholesale distributor.
� Timing of final regulations on Taxable Medical Device
�
� Published guidance on additional MDET issues?
� Private letter rulings
- Proper Constructive Price - Section 5.13 of Rev. Proc. 2012-1.
- Whether a medical device is a taxable medical device.
- Other issues
� Agreements through Compliance Assurance Process
� Technical Advice
Implementation Issues
• Taxable and Nontaxable Sales and Uses
• Registration and Certification Requirements and Procedures
• Reporting, Payment and Penalties
• Manufacturing Activities
• What is the “Price”
• Leases and Rentals
• Accounting Systems and Procedure
• Ruling Process/Additional Guidance
2
3
Taxable and Nontaxable Sales and Uses
Taxable Sales and Uses
• Section 4191 of the Internal Revenue Code imposes a 2.3 percent excise tax on the sale of taxable medical devices by a manufacturer, producer , or importer.
• What is a Sale?
− The rules generally provide that a sale occurs when title to the taxable article passes from the manufacturer to a purchaser.
� When title passes is dependent upon the intention of the parties as gathered from the contract of sale and the circumstances.
− What if the medical device is computer software that is licensed?
4
Taxable Sales and Uses
• Who is a Manufacturer? A producer or importer− Producer: Any person who produces a taxable article from new
or raw material, or from scrap, salvage or junk material by:
� Processing or changing the form of the article, or
� Combining or assembling 2 or more articles
− Importer: Any person who brings a taxable item into U.S. (or withdraws from a customs bonded warehouse) for sale or use in the U.S.
• Manufacturer is liable for payment of tax
5
Taxable Sales and Uses
• Taxable event: Tax attaches when title passes from manufacturer to purchaser. − Look to intent of parties as expressed in sales contract.
− In the case of a sale on credit, the tax attaches whether or not the purchase price is actually paid.
− If no expressed intent, look to legal rules of presumption in jurisdiction where sale occurs.
6
Taxable Sales and Uses
• Partial payments: Tax attaches at time each partial payment is received when taxable articles are:− Leased;
− Sold conditionally;
− Sold on installment with chattel mortgage (i.e., transfer of rights in tangible personal property as security for payment of money or performance of some other act), or
− Sold on installment with title passing in future
− Licenses?
7
Taxable Sales and Uses – Exemptions?
• Sales to State and local governments—NOT exempt
• Sales to nonprofit educational organizations—NOT exempt.
• Sales to qualified blood collector organizations—NOT exempt.
• Sales to affiliated company—TAXABLE. Special rules apply for determining the sales price.
• Use by manufacturer—generally TAXABLE
− Lease of medical device by manufacturer is considered a sale
8
Taxable Sales and Uses – Special Issues
• Demonstration products
− e.g. medical device that is provided “free of charge” for promotional purposes
• Evaluation projects
• Free samples
• Loaned equipment
• Free products as a bonus for selling/buying a certain quantity
9
Nontaxable Sales and Uses – Further Manufacture• Sales for use by the purchaser for further manufacture, or
for resale by the purchaser to a second purchaser for use by such second purchaser in further manufacture, are exempt
• Manufacturer may be relieved of liability. Reg. §48.4221-1(b)(1)
• If purchaser buys articles tax free and resells them or uses them other than in the manufacture of another article, the purchaser is liable for the tax.
10
Nontaxable Sales and Uses – Further Manufacture (cont’d)• If sold for resale for further manufacture — Within 6
months of date of sale by the manufacturer, the manufacturer must receive proof that the device has been sold for further manufacture. Reg. § 48.4221-2(c)
• Consequences of failure to receive proof.
11
Nontaxable Sales and Uses – Export
• Sales for export, or for resale by the purchaser to a second purchaser for export, are exempt.
• Product must be exported within six months of sale and evidence of export provided to manufacturer. See Reg. § 48.4221-3(d) for evidence that qualifies.
• If manufacturer does not receive proof of export, the manufacturer is liable for the tax.
12
Nontaxable Sales and Uses – Additional Requirements• Manufacturer, first purchaser and second purchaser (in
the case of resales) must be registered . IRC §4222(a)
− Does not apply to foreign purchasers of articles sold or resold for export. But see Reg. §48.4221-3(b)
• If the purchaser is required to be registered, the purchaser must give the manufacturer its registration # and certify the exempt purpose. Certification must be in writing and may be noted on the purchase order
• Manufacturer must indicate to purchaser that the articles normally would be subject to tax.
13
Nontaxable Sales and Uses – Failure to Claim Exemption• A credit or refund of the manufacturers excise tax may be
available if a tax-paid article is exported or used for an exempt purpose, such as further manufacture.
14
Registration and Certification
15
Registration with the U.S. Food and Drug Administration• Who must register?
− The FDA generally requires owners or operators of business that manufacture, prepare, propagate, compound, assemble, process, repackage or re-label medical devices intended for human use (“Manufacturers”) to register their establishments and list their devices upon first entering into operation.
� Applies to businesses located in the United States, or in a foreign country that export devices to the United States
� Information must be updated with U.S. Food and Drug Administration annually
16
Registration with the IRS
• Who must register?
− In general, manufacturers and importers must register their (i) businesses and (ii) medical devices with IRS on Form 637, “Application for Registration (For Certain Excise Tax Activities ).”
− Status of revised form
− The application must be reviewed and approved before person is registered for any activity. The review may include inspection of the applicant’s premises.
− If an application is approved, the IRS will issue a Letter of Registration. The letter will include the activities for which the applicant is registered, the effective date of the registration, and a registration number.
17
Registration of Purchaser Seeking Exemption• Who must register?
– Tax-free sale of taxable medical device generally may be made only if manufacturer, first purchaser and second purchaser (if any) have been registered by the IRS.
– Exception: Persons whose principal place of business is not in the U.S. not required to register to purchase tax free for export
• Generally, the purchaser of a taxable article must provide the purchaser’s registration number to the manufacturer and certify the exempt purpose for which the article will be used. Information must be in writing and may be noted on the purchase order furnished by the purchaser
18
Registration of Purchaser Seeking Exemption – Next Steps(cont’d)• When new Form 637 is issued, complete and submit the
form to the IRS.• Remember that excise tax law does not allow for
consolidated returns. Thus all affiliates that manufacture or import and then sell taxable medical devices must register. “Disregarded entities” must register separately from their owners.
• If you manufacture or import taxable medical devices and expect to sell for further manufacture, contact customers to whom you expect to make exempt sales and encourage them to complete the form immediately.
19
Reporting, Payment and Penalties
20
Form and Schedules for Reporting
• Who Must File?
– The party incurring liability for federal excise taxes or responsible for collecting federal excise taxes must file Form 720 (Quarterly Federal Excise Tax Return). Thus, manufacturers and importers must file.
– The excise tax rules do not include procedures for consolidated returns. Each corporate affiliate that manufactures or imports and sells taxable medical devices must file.
– Each “disregarded entity,” such as a wholly owned LLC, that manufactures or imports and sells taxable medical devices must file separately.
21
Form and Schedules for Reporting
• When to file?– The party must file on a quarterly basis or, upon a failure in
compliance, possibly on a monthly or semi-monthly basis (due last day of month after quarter end)
• Purpose of the filing– Look back filing to “true up” the net excise tax liability paid through
the semimonthly payments made throughout the quarter
• Recordkeeping– Filers must maintain tax return, records, and accounts of all
transactions supporting all claims and exemptions for at least 4 years
22
Procedures for Payment
• General
− Semi-monthly deposits (twice a month) of excise tax estimates are required unless the net liability for excise taxes does not exceed $2,500 for quarter.
23
Procedures for Payment
• How and when to make deposits
− Must use electronic funds transfers (ETF) to make excise tax deposits (via Electronic Federal Tax Payment System).
− Due on the 29th of the month (for the first semimonthly period) and the 14th day of the following month (for the second semimonthly period).
− Transaction must be initiated one day before the deposit is due.
24
Procedures for Payment
• Amount of Deposit
− Deposit must be 95% of the net tax liability for the period unless safe harbor applies.
− Can elect to determine semimonthly liability by dividing monthly liability by two
− Safe Harbor — If each deposit equals 16.67% (or 1/6) of the total net tax liability for the entire look-back quarter (the 2nd calendar quarter preceding the current quarter). Underpayment must be made with return for quarter
25
Penalties and Interest
• Penalties and interest may result from:
− Failure to keep adequate records
− Failure to file returns (Form 720)
− Failure to pay taxes (or make deposits)
− Filing returns late
− Filing false or fraudulent returns or making false statements
− Paying taxes late (or making deposits late)
− Failing to register
− Misrepresenting that tax is excluded from the price of an article
26
Penalties and Interest
• Claims
− Criminal penalties for false or fraudulent claims
� Including refund claims for excessive amounts (penalty is the greater of two times the excessive amount or $10)
• Failure to Register
− Penalty for failure to register if required to register, unless due to reasonable cause, is $10,000 for the initial failure and $1,000 each day thereafter.
27
Overpayment, Refunds and Credits
• Form 8849, Claim for Refund of Excise Taxes
• Form 720, Quarterly Federal Excise Returns (for credits)
• Product used for exempt purpose (exported or used in further manufacture)
• Price adjustment by reason of return or repossession of the article or bona fide discount or rebate.
• No interest on refunds
28
Overpayment, Refunds and Credits
• Credit or refund can be claimed by manufacturer.
• If tax-paid device is exported, the exporter or shipper may claim a credit or refund if the manufacturer waives its right. Claim must include proof of export and other information
• If tax-paid device is used in subsequent manufacture, the subsequent manufacturer may claim the credit or refund.
29
Overpayment, Refunds and Credits Exports – Claim by Manufacturer• To claim a credit or refund in the case of an export,
manufacturer must certify that one of the following applies:
− Claimant sold the article at a tax-excluded price.
− Claimant has repaid or agreed to repay the ultimate vendor for the product.
− Claimant has obtained the written consent of the ultimate vendor to make the claim.
− Claimant has repaid the amount of the tax to the ultimate purchaser or has filed the consent of the ultimate purchaser to the allowance of the credit or refund.
• Evidence must be submitted. Reg. §48.6416(b)(2)-3
30
Overpayment, Refunds and Credits Exports – By Exporter• Exporter or shipper may claim refund or credit if
manufacturer waives claim and other conditions satisfied (supporting evidence). See Reg. §48.6416(e)-1
31
Overpayment, Refunds and Credits Further Manufacture – Claim by Subsequent Manufacturer
• To claim a credit or refund of tax paid on a device for a price adjustment, the manufacturer must include a statement that contains the following:
− Description of circumstances that gave rise to price adjustment
− Identification of device
− Price at which device was sold, amount of tax paid, and date on which it was paid
− Name and address of the purchaser
− Amount repaid to purchaser or credited to purchaser’s account. Reg. §48.6416(b)(1)-4.
32
Overpayment, Refunds and Credits Price Adjustment by Manufacturer• To claim a credit or refund of tax paid on a device for a
price adjustment, the manufacturer must include a statement that contains the following:
− Description of circumstances that gave rise to price adjustment
− Identification of device
− Price at which device was sold, amount of tax paid, and date on which it was paid
− Name and address of the purchaser
− Amount repaid to purchaser or credited to purchaser’s account. Reg. §48.6416(b)(1)-4
33
Manufacturing Activities
34
Manufacturing Activities – Kitting and Contract Manufacturing• Definition of manufacturer
− any person who produces a taxable article from scrap, salvage, or junk materials, or from new or raw material, by processing, manipulating, or changing the form of an article or by combining or assembling two or more articles
35
Manufacturing Activities - Kitting
• Proposed regulations’ position on kitting
− Kits are treated as taxable medical devices if the kit is listed with the FDA as a device pursuant to FDA requirements
− For such kits, kitting is considered to be a manufacturing activity and the kitter is the manufacturer liable for the tax
− If the kitter pays the tax but a manufacturer of a device that is part of the kit also paid tax on that device and sold the device to the kitter at the tax-included price, then the kitter is entitled to a refund or credit for that overpayment of tax
− If the kit includes taxable and nontaxable devices, the price of the kit is subject to the tax without reduction for the price of nontaxable devices, on the basis that the individual devices in the kit “have lost their identity as separate articles”
36
Manufacturing Activities – Contract Manufacturing• Rules on contract manufacturing
− The determination of who is the manufacturer is based on facts and circumstances
− Substance rather than form controls
− See Rev. Rul. 58-134, Rev. Rul. 60-42, and Polaroid v. US, 235 F.2d 276 (1st Cir. 1956)
• Proposed regulations’ position on use of income tax rules on contract manufacturing (e.g., §954) - NO
37
What Is the “Price” Subject to Tax?
38
What is the “Price” Subject to Tax?
• The price for which sold is the “total consideration paid for the article, whether that consideration is paid in the form of money, services, or other things” [Reg. §4216(1)-1(a)]
• Included Charges:− Separate charges for tools and dies
− Charges for coverings, containers and packing, whether or not identified on the invoice or separately billed
− Commissions to manufacturers’ agents or allowances, payments or adjustments made to or for the benefit of anyone other than the purchaser
• Excluded Charges: − Excise tax
− Transportation, delivery, insurance, or installation charges
39
Rebates and Discounts
• Readjustments to sales price such as allowable discounts, rebates, bonuses, etc. are treated as not being anticipated.
• The sales price thus must be based on the original price unless the readjustments have actually been made prior to the close of the period for which the tax upon the sale arises
• If the price is subsequently readjusted, credit can be taken against the tax due on a subsequent return
40
Items Furnished Under Warranty
• If an article is returned by reason of the failure of the article under warranty and a new article is furnished free or at reduced price, then the tax on the new article is computed based on the price, if any, for the new article [Reg. §4216(a)-3(b)]
• See Reg. §48.6416(b) for circumstances under which return of first article constitutes a price adjustment for which credit or refund can be made
41
Leases and Rentals
42
Taxable Event
• The lease of an article by the manufacturer (including importer) is treated as a sale
• Tax is paid on each rental payment, rather than at the time of sale
• If medical device is sold to a lessor (including an affiliate), the sale is the taxable event, and rental payments would not be taxed
43
Amount of Tax
• 2.3% of each rental payment until the total of the tax payments under the lease and any prior lease equals the “total tax.” [IRC §4217(b)]
• “Total Tax”: Tax computed on constructive sale price “which would be determined under section 4216(b) if such article were sold at retail on the date of the first lease” [IRC §4217(c)(1)].
• “Total Tax” limitation applies only if the person making the lease or the prior lease was also engaged in the business of selling in arm’s length transactions the same type and model of article. [IRC §4217(d)(1)]
44
� Overview:
� Supply Chain Mapping
� Defining the Tax Base
� Determining When the Liability Arises
� Amount of Liability
� Compliance/IT considerations
� Does the way we obtain ownership of taxable medical
devices potentially make us liable for the tax
� Do we make it?
� Did we import it?
� Are we treated as if we made it?
� What about:
� Kitting
� Installation and/or periodic servicing
� Training
� Repairs
� Refurbishing
� Which legal entities in our structure have compliance
obligations
� Single US entity
� Foreign parent
� Domestic parent
� Multiple US entities
� Central domestic distributor
� Product Exemptions
� Mapping FDA product codes onto item masters
� Exemptions lost to kitting
� Export transactions
� Can we prove it?
� Further manufacturing
� Whose liability?
� Is it ours or our vendor’s?
� Can double taxation be avoided?
� Vendor policies
� Hospitals
� Which transaction triggers the liability
� First sale after manufacturing
� Some common “foot faults” when determining when
manufacturing ends
� Sterilization?
� Imported product issues
� Identifying uses treated as sales
� We don’t sell our equipment
� Rental as use
� Valuation issues
� Pricing determinations
� Pricing adjustments
� What can be excluded?
� 4216(a) charges
� Other charges not properly not included as manufacturing or
selling expense Reg.§ 48.4216(a)-2
� Many ERP environments
� SAP
� QUAD
� JDE
� Oracle
� QuickBooks
� Data processes – What is needed?
� Tax calculation
� ERP reporting
� Tax audit support
� Return preparation
� How much to automate?
� Initial
� Registrations
� Exemption certificates
� Recurring
� Payment procedures
� Filing of quarterly Forms 720
� Record retention
� Supplier relationship changes
� Item master changes
� Acquisitions
� Develop and sell
� Demonstration and training units
� Lent tools associated with implantables
� Tools are returned after use with implantable device, then
sterilized and reused
� Are they depreciated?
� Pre-2013 inventory of tools
� Sales
� Retail exemption
� Kitting
� Loss of the retail exemption
� Purchased product both resold and kitted
� Repairs
� Tools
� Capital equipment
� Taxable or not?
� Does the retail exemption apply?
� Purchase, use, and design tests
� Rental or sale?
� Reagent rental model
� Razor/razor blade business model
� Case 1: The specified and recurring fee for the disposables
includes an implicit charge for the use of capital equipment.
Customers who own their capital equipment purchase at a lower
price.
� Case 2: The specified and recurring fee for the disposables
includes an implicit charge for the use of capital equipment, with
no transactions involving customer-owned equipment.
� Rental issues
� Does the first use rule exempt property used prior to 2013?
� Definition of a lease and the cap on rental payments
� Contracts for a capability v. a specific piece of equipment
Medical Device Excise TaxTechnical Overview/Systems Approach/Automation Considerations
Stephen MetoyerPrincipalDeloitte Tax LLP
September 20, 2012
Copyright © 2012 Deloitte Development LLC. All rights reserved.2
Agenda
• Overview
• MDET Solution Development Life Cycle• Impact Analysis• Business Decisions• Requirements Gathering• Solution Development
• Reporting and Systems Readiness
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Overview – Medical Device Excise Tax
3
• Beginning January 1, 2013, a 2.3% excise tax is levied on the sale of any taxable medical device. The tax is imposed on the manufacturer, producer, or importer.
• The tax applies to sales of any medical device intended for humans (as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act)
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Overview – What is a Medical Device?
4
Sec 201(h) of the Federal Food, Drug, and Cosmetic Act:The term "device“ means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is--1. recognized in the official National Formulary, or the United States Pharmacopeia,
or any supplement to them,2. intended for use in the diagnosis of disease or o ther conditions, or in the
cure, mitigation, treatment, or prevention of disea se, in man or other animals, or
3. intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. (i.e., not a drug)
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Overview – Exemptions
5
Three Exceptions/Exemptions:1. Devices sold at Retail to the public for individual use (eyeglasses,
hearing aids, etc.)2. Devices sold for further manufacture3. Devices sold for export
Observations:• Information technology implications may require reconfiguring ERP
systems• Registration process and exemption certificate management will be
required
Copyright © 2012 Deloitte Development LLC. All rights reserved.
The Implications are Far Reaching
6
Copyright © 2010 Deloitte Development LLC. All rights reserved.7
Integrated BRD
FRICEWFunctional
specs
Tax business requirements
Taxdata elements
BRDWorkshops
Fit/Gap assessment
Tax design blueprints
Configurationdesign
Processdesign
Solution Approach
Copyright © 2012 Deloitte Development LLC. All rights reserved.
MDET Solution Development Life Cycle
8
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Excise Tax Impact Analysis
9
Copyright © 2012 Deloitte Development LLC. All rights reserved.
MDET Business Decisions
In some solution development projects requirements are gathered and business decisions are made based upon gathered requirements. However, with the complexit y of MDET, it is clear that certain business decisions might d rive how requirements are gathered.
10
Timing / Type of Calculation
Tax Base
Pass-through and financial impact
Communications
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Business Decisions - Timing / Type of Calculation
Real-time Calculation• Leverages existing systems and
transactional events to calculate tax
• Tax is calculated and booked at transaction time and level
Batch Process Calculation• Perform offline calculation of
MDET in batch• Can be done via reporting / BI
tools
Use of Tax Software?• Content• Taxability• Calculation• Taxable transaction event• Perform Calculation with ERP
native functionality
11
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Business Decisions - Tax Base
The taxable price for MDET will be either the actual or a constructive sales price. Under either the actual or constructive sales price, certain items are either included or excluded. (One word of caution, certain of the CSP scenarios don’t permit the use of the exclusions listed below. )
A taxpayer only falls into the CSP rules if the article is:• Sold at retail *• Sold on consignment, or• Sold (otherwise than through an arm’s length transaction) at less than fair market value*
* A sale at retail for these rules is a sale of an article to a purchaser who intends to use or lease the article rather than resell the article.
12
Inclusions
• Coverings & containers• Charges incident to placing the article in a
condition to be packed and ready for shipment
• Standard warranty
Exclusions
• The excise tax itself• The actual cost of transportation, delivery,
insurance, installation and other expenses incurred in connection with placing the article in the hands of the purchaser
• Discounts, rebates and similar allowances actually granted to the purchaser
• Warranty paid at the purchaser’s option
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Business Decisions – Pass through and financial impa ct
Will the tax get passed through to
customers?
Will the tax be presented as a line item to customers?
What information is being divulged regarding cost
structure?
Is the price elastic enough to absorb
the perceived price increase?
How is the impact measured?
- Financial- Customer- Tax Authority
13
YES
NO
YES
NO
• Certain business decisions related to financial impact, customer relationship, market conditions will drive the required robustness of a system solution for reporting and or calculation.
• It is often the case that these business decisions are far more complicated than the actual systems design and implementations.
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Business Decisions - Communications
Internal
Finance & controllers
Tax compliance
Sales, contracting & customer relations
Supply chain management
Quality and Regulatory
Information technology
External
Customers
Suppliers
Governmental Authorities
Business partners
14
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Business Requirements
15
Description
Inputs and ToolsActivities
1.1 Systems Requirements Definition
• Conduct workshops with functional areas to determine process flows and surface requirements
• Review transactional data for financial transactions
• Review product lines to determine taxable medical devices
• Identify applicable exemptions and/or exclusions
• Identify high-level MDET requirements
1.2 Fit-Gap Determinations
• Assess impact of requirements on current processes
• Assess Impacts to current systems
• Assess system and process fit-gap for requirements
1.3 Requirements / IT Systems Environment Review D ocumentation
• Prepare, review, and finalize Requirements
Specific Outcomes
High-level MDET requirements serves as the baseline to develop systems and business processes. These requirements must be met in order to lay the foundation for designing the MDET solution. Particular focus should be placed on the business structure and strategy, tax impositions, and the processes that impact them. The requirements are compared to the potential solution alternatives (once identified) to identify potential gaps.
• Tax
• Finance
• IT
Resourcing
Week 1 2 3 4 5 6 7
Potential timing
1. System Requirements Development
1.1 System Requirements Definition1.2 Fit-Gap Determinations1.3 Requirements / IT Systems Environment Review
Documentation
Tax Blueprint Industry Print Fit-Gap Template
System Requirements IT Systems Environment Review
Key Activity
Key Deliverable
Workshop
Master Data • Ability to identify FDA registered devices as part of Master Data
• Ability to differentiate items purchased (fully completed medical devices) for resale vs. items used for further manufacturing
Incidence of MDET
• Ability to determine the Manufacturer/Producer/Importer (“MPI”) in supply chain
• Ability to differentiate physical product from services for MDET treatment
MDET Calculation
• Ability to calculate the MDET on cross legal entity transactions
• Ability to calculate the MDET across multiple ERP systems
• Ability to post MDET to the appropriate tax liability account in GL
Exemptions
• Ability to track exemption certificates related to purchases and sales of FDA-listed medical devices or otherwise determine that double tax is not paid
• Ability to track medical devices that are subject to further manufacturing
Reporting
• Ability to track price adjustments & rebates to recover tax previously paid
• Ability to generate reporting to track transactions where refunds are processed
• Ability to generate reporting for MDET compliance and audit purposes
Business Requirements
Design • Collaborative work with Information technology to develop a solution• Accounts for all aspects of MDET compliance (record to report)
Build
• Primarily a Information Technology effort to configure new reports, functionality etc. • Involves configuration, coding, and development of offline tools• Should include unit testing of built solutions
Test• Integrated testing of the designed and built solution(s)• Test all elements of solution
Cut-Over
• Exception handling • Returns• Communication strategy
Design – Build – Test – Cut-Over
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Reporting and Systems Readiness: Compliance, Audit, Ad -Hoc
18
Reporting
How will data be captured and stored?
How can the business
access the data when needed?
How can the integrity of the
data be confirmed ?
How do we prepare the
infrastructure for ad-hocreporting?
How do we consolidate
MDET-related data when
multiple ERPS are involved?
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Reporting and Systems Readiness: Reporting and System Complexities
19
Currently we have clients that are taking different approaches to capturing relevant data, calculating the tax, and generating reports that can be used to identify tax paid on registered medical devices.
1.For some medical device manufacturers it is impractical to determine taxability and calculate MDET on a transactional basis (e.g. real-time), since it does not follow the manufacturer->distributor->end customer sales model contemplated by excise tax law (i.e. the manufacturer and distributor are one in the same, and this is where tax applies)
2.Exemptions and exclusions are not ordinarily identifiable back to a transaction level, freight and other exclusions are aggregated and may be embedded in cost of good sold
3.Systems that can be used to store the detailed source data for a specified time period for audit defense and tax planning purposes may require some modification to store MDET related data
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Reporting and Systems Readiness: Sample SAP Report
20
This presentation contains general information only and Deloitte is not, by means of this presentation, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This presentation is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified professional advisor. Deloitte shall not be responsible for any loss sustained by any person who relies on this presentation.
About this presentation
About DeloitteDeloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
Copyright © 2012 Deloitte Development LLC. All rights reserved.Member of Deloitte Touche Tohmatsu Limited